Viridian Therapeutics, Inc. VRDN Other Operating Income Expense Net
Other Operating Income Expense Net at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s other operating income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s other operating income expense net?
- Viridian Therapeutics, Inc. (VRDN) reported other operating income expense net of -$672K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s other operating income expense net changed year-over-year?
- Viridian Therapeutics, Inc.'s other operating income expense net decreased by 1766.7% year-over-year, from -$36K to -$672K.